Proteomics International Laboratories Ltd (ASX:PIQ)
0.3800
0.00 (0.00%)
Feb 19, 2026, 3:54 PM AEST
ASX:PIQ Market Cap
ASX:PIQ has a market cap or net worth of 62.77 million as of February 18, 2026. Its market cap has decreased by -24.54% in one year.
Market Cap
62.77M
Enterprise Value
51.81M
Revenue
3.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.38
Market Cap Chart
Since April 16, 2015, ASX:PIQ's market cap has increased from 11.39M to 62.77M, an increase of 451.34%. That is a compound annual growth rate of 17.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 62.77M | -41.47% |
| Dec 31, 2025 | 107.24M | 2.33% |
| Dec 31, 2024 | 104.80M | -4.28% |
| Dec 29, 2023 | 109.49M | -0.29% |
| Dec 30, 2022 | 109.81M | -14.46% |
| Dec 31, 2021 | 128.37M | 53.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 102.44M |
| LTR Pharma | 94.52M |
| Cynata Therapeutics | 90.66M |
| Alterity Therapeutics | 87.00M |
| Imugene | 80.38M |
| Radiopharm Theranostics | 77.97M |
| EZZ Life Science Holdings | 76.92M |
| Neurizon Therapeutics | 67.49M |